Catalyst Wire Dossier Catalyst Wire Dossier

Buprenorphine (generic)

BUPRENORPHINE · Hikma Pharmaceuticals USA Inc.
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Buprenorphine (generic), covering 2011-05-10 to 2022-06-17. Get the full timeline:

Most recent: FDA Approved: BUPRENORPHINE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

See pricing